The role of SmgGDS in the pleiotropic effects by statins
The role of SmgGDS in the pleiotropic effects by statins
批准号:
23659071
负责人:
SHIMOKAWA Hiroaki
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
我们验证了我们的假设,即小gtp结合蛋白GDP解离刺激剂(SmgGDS)在内皮细胞中3-羟基-3-甲基戊二酰辅酶a还原酶抑制剂(他汀类药物)抑制Rac1信号通路的分子机制中起着至关重要的作用。在本研究中,我们证明了他汀类药物通过上调SmgGDS发挥其多效作用,从而导致动物和人类的Rac1降解和氧化应激降低。
英文摘要
We tested our hypothesis that small GTP-binding protein GDP dissociation stimulator (SmgGDS) plays a crucial role in the molecular mechanisms of the Rac1 signaling pathway inhibition by3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) in endothelial cells. In the present study, we demonstrated that statins exert their pleiotropic effects through SmgGDS upregulation with a resultant Rac1 degradation and reduced oxidative stress in animals and humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Mechanisms for enhanced endothelium-derived hyperpolarizing factor-medited responses in microvessels in mice.
增强小鼠微血管内皮源性超极化因子介导的反应的机制。
DOI:
--
发表时间:
2012
期刊:
Circulation Journal
影响因子:
3.3
作者:
[Ohashi J, Sawada A, Shimokawa H, et al.]
通讯作者:
et al.
スタチンの用法、用量を決定する方法
如何使用他汀类药物,如何确定剂量
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[]
通讯作者:
内皮由来過分極因子の医学的意義.血栓と循環
内皮源性超极化因子的医学意义。
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[下川宏明, 神戸茂雄]
通讯作者:
神戸茂雄
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Yuichiro Tamaki, Masashi Honda, Yuka Muroi, Tomio Arai, Haruhiko Sugimura, Yoichi Matsubara, Shuichi Kanno, Masaaki Ishikawa, Noriyasu Hirasawa, Masahiro Hiratsuka, 諏訪 雅子,沼澤 聡,吉田 武美, Shimokawa H]
通讯作者:
Shimokawa H
肺高血圧診療の進歩をみる.特集にあたって
纵观肺动脉高压治疗进展。关于专题
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Sekine S, Mitsuki K, Ito K, Kugioka S, Horie T., 下川宏明]
通讯作者:
下川宏明
共 30 条
The possibility of pleiotropic effects of Novel Oral Anticoagulants (NOAC) on Rho-kinase-cyclophilin A System
-
批准号:25670379
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2013
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Molecular mechanisms for NOSs-mediated responses in microvessels
-
批准号:22390154
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2010
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Experimental and Clinical Studies on the Significance of Endothelium-Derived Hyperpolarizing Factor (EDHF)
-
批准号:16209027
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2004
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
International Collaboration Study on the Racial Difference in Coronary Vasospasm
-
批准号:15256003
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$22.3万
-
财政年份:2003
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Development of Nanomedicine for the Treatment of Cardiovascular Diseases
-
批准号:13557068
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2001
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Role of Rho/Rho-kinase-mediated pathway in the pathogenesls of atherosclerosis
-
批准号:13307024
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$35.19万
-
财政年份:2001
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Basic and clinical studies on the role of inflammatory mechanisms in the pathogenesis ischemic heart disease
-
批准号:12470158
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2000
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Development of Chronic Heart Failure Model Caused by Inflammatory Cytokines and Establishment of Prophylactic and Therapeutic Strategies for the Heart Failure
-
批准号:08557050
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1996
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
The role of inflammatory mechanisms in the pathogenesis of ischemic heart disease. Basic and clinical studies.
-
批准号:07457173
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1995
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Role of Inflammatory Cytokines in the Development and Progression of Ischemic Heart Diseases-Experimental and Clinical Studies-
-
批准号:05454274
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1993
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
海外基金